[1]
Sreeparvathy, R. et al. 2024. Platelet Rich Fibrin Matrix (PRFM) and Peripheral Blood Mesenchymal Stem Cells (PBMSCs) in the management of intraosseous defects: a randomized clinical trial. Journal of Applied Oral Science. 32, (Aug. 2024), e20230442. DOI:https://doi.org/10.1590/1678-7757-2023-0442.